Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
June 30, 2026 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 29, 2026 144 Filed by "insiders" prior intended sale of restricted stock. View HTML
June 22, 2026 4 Statement of changes in beneficial ownership of securities View HTML
June 22, 2026 4 Statement of changes in beneficial ownership of securities View HTML
June 22, 2026 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 22, 2026 4 Statement of changes in beneficial ownership of securities View HTML
June 22, 2026 4 Statement of changes in beneficial ownership of securities View HTML
June 22, 2026 4 Statement of changes in beneficial ownership of securities View HTML
June 22, 2026 4 Statement of changes in beneficial ownership of securities View HTML
May 12, 2026 SCHEDULE 13G SCHEDULE 13G - Description View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us